Clinical Trials Browser

OTHER_GOV × Carcinoma, Non-Small-Cell Lung × Endostatins × Clear all

NCT06618391 2024-10-01

Local Injection and Systemic Therapy in the Treatment of NSCLC.

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT03008109 2017-01-04

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung